That admission is what some in the field call recursive self-improvement (RSI), the point at which large language models ...

Recursion harnesses AI for large-scale drug discovery, while Summit's betting on a single oncology candidate. How do their ...

Recursion Pharmaceuticals (RXRX) closed at $3.23 in the latest trading session, marking a +2.22% move from the prior day.

Recursion Pharmaceuticals combines artificial intelligence, automation, and biotechnology research across multiple ...

The Democratic nominee for governor should oppose the ills and weaknesses of generative AI, crafting policies that instead ...

Recursion and Exscientia, two pioneers in artificial intelligence (AI)-based drug development, have completed a business combination that they vowed will enhance their ability to carry out drug ...

OpenAI is bulking up before its IPO, landing Transformer co-inventor Noam Shazeer from Google DeepMind and former Trump AI ...

The current calendar covers exhibitions dedicated to Brâncuşi’s legacy, highlights from the collections of local museums, and ...

Most people have experienced it. You think about someone you have not seen in years, and they call that afternoon. A stranger says exactly what you needed to hear during a difficult week. A chance ...

As the nation marks its 250 anniversary, the Smithsonian invites educators to imagine the future we want to build. High ...

In the AI value chain, application-layer leaders like Palantir and ServiceNow may win long term as chip/cloud margins ...

Dean Ball, a former top White House official who helped shape the Trump administration’s artificial intelligence policy, is set to join OpenAI, according to four people familiar with the matter who ...